Analysts expect ProQR Therapeutics N.V. to report revenue of 4.56 M for Q3 26, against a range of 4.27 M to 4.85 M. The most recent reported quarter, Q2 26, came in at 10.00 M, a 131.4% beat against the 4.32 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.28 M | 4.22 M | 4.89 M | 4.50 M | 3.38 M | 5.54 M | 2.35 M | 10.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 12.67 M | 5.33 M | 5.82 M | 6.29 M | 5.98 M | 7.18 M | 5.50 M | 4.69 M | 4.85 M | 4.59 M | 4.27 M | 4.43 M | 4.12 M | 5.16 M | 13.52 M | 19.51 M | ||||||||||
| Low Estimate | 10.67 M | 4.60 M | 4.95 M | 5.52 M | 5.22 M | 6.51 M | 5.12 M | 3.95 M | 4.27 M | 4.06 M | 3.84 M | 3.63 M | 3.38 M | 4.60 M | 11.11 M | 17.26 M | ||||||||||
| Consensus Estimate | 11.67 M | 4.96 M | 5.39 M | 5.91 M | 5.60 M | 6.84 M | 5.31 M | 4.32 M | 4.56 M | 4.33 M | 4.06 M | 4.03 M | 3.75 M | 4.88 M | 12.32 M | 18.39 M |
Analysts expect ProQR Therapeutics N.V. to report earnings per share of -0.11 for Q3 26, against a range of -0.12 to -0.10. The most recent reported quarter, Q2 26, came in at -0.09, a 35.7% beat against the -0.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.11 | -0.09 | -0.11 | -0.14 | -0.12 | -0.09 | -0.15 | -0.09 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.12 | -0.11 | -0.10 | -0.09 | -0.10 | -0.09 | -0.13 | -0.13 | -0.10 | -0.13 | -0.13 | -0.15 | -0.12 | -0.13 | -0.14 | -0.14 | ||||||||||
| Low Estimate | -0.14 | -0.11 | -0.10 | -0.09 | -0.12 | -0.11 | -0.15 | -0.15 | -0.12 | -0.15 | -0.15 | -0.17 | -0.12 | -0.15 | -0.14 | -0.16 | ||||||||||
| Consensus Estimate | -0.13 | -0.11 | -0.10 | -0.09 | -0.11 | -0.10 | -0.14 | -0.14 | -0.11 | -0.14 | -0.14 | -0.16 | -0.12 | -0.14 | -0.14 | -0.15 |
Pull Wall Street consensus for ProQR Therapeutics N.V. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PRQR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PRQR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PRQR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();